SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-009136
Filing Date
2017-10-05
Accepted
2017-10-05 08:35:13
Documents
3
Period of Report
2017-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT opxa_8k.htm 8-K 28672
2 PRESS RELEASE opxa_ex991.htm EX-99.1 14769
3 IMAGE acer001.jpg GRAPHIC 7399
  Complete submission text file 0001654954-17-009136.txt   55342
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 171123344
SIC: 2834 Pharmaceutical Preparations